Serum Myostatin among Excessive Drinkers.
Candelaria Martín-GonzálezOnán Pérez-HernándezAlen García-RodríguezPedro Abreu-GonzalezPaula Ortega-ToledoCamino María Fernández-RodríguezJulio César Alvisa-NegrínAntonio Martínez-RieraEmilio González-ReimersPublished in: International journal of molecular sciences (2023)
Myostatin acts as a negative regulator of muscle growth. Its effect on fat mass is subject to debate. Among alcoholics, there is a high prevalence of muscle atrophy, and increased fat deposition has been also described in these patients. Myostatin could be involved in these alterations, but its relationships with body composition have been scarcely studied in alcoholic patients. To analyze the behavior of myostatin among alcoholics and its relationship with alcohol intake, liver function, and body composition. We investigated serum myostatin in 59 male patients and 18 controls. Patients were all heavy drinkers admitted with organic complications related to excessive ethanol ingestion. Densitometry analysis was used to assess body composition in 46 patients. Handgrip was assessed in 51 patients. Patients showed lower myostatin values than controls (Z = 3.80; p < 0.001). There was a significant relationship between myostatin and fat at the right leg (ρ = 0.32; p = 0.028), left leg (ρ = 0.32; p = 0.028), trunk (ρ = 0.31, p = 0.038), total fat proport ion (ρ = 0.33, p = 0.026), and gynecoid fat distribution (ρ = 0.40, p = 0.006) but not with lean mass (total lean ρ = 0.07; p = 0.63; trunk lean ρ = 0.03; p = 0.85; lower limbs ρ = 0.08; p = 0.58; upper limbs ρ = 0.04 p = 0.82; android ρ = 0.02; p = 0.88, or gynoid lean mass ρ = 0.20; p = 0.19). In total, 80.43% of patients showed at least one criterion of osteosarcopenic adiposity (OSA). Myostatin was related to OSA obesity. We also observed higher myostatin values among patients with body mass index > 30 kg/m 2 . Serum myostatin was lower among excessive drinkers, and it was related to increased fat deposition among these patients but not to lean mass, handgrip, or bone mineral density.
Keyphrases
- alcohol consumption
- body composition
- end stage renal disease
- bone mineral density
- newly diagnosed
- ejection fraction
- body mass index
- chronic kidney disease
- prognostic factors
- adipose tissue
- type diabetes
- obstructive sleep apnea
- peritoneal dialysis
- postmenopausal women
- metabolic syndrome
- insulin resistance
- risk factors
- weight loss
- transcription factor
- solid state